Plain-English translation of NCT07862712 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
United States
Phase
Post-approval monitoring
Sponsor
VA Office of Research and Development
Enrollment target
~70 participants
Started
March 2027
Primary completion
December 2031
Age range
21 Years – 75 Years
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Katharine J Liang, MD PhD
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.